CD63 and breast cancer: Western blot analysis showed that EVs in serum of healthy controls, benign individuals and BC patients were rich in EV markers, and CD9, CD63 and calnexin were negative, indicating that the purity and abundance of serum EVs in this study were ideal (Fig. 1b).